{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:44:33Z","timestamp":1767869073925,"version":"3.49.0"},"reference-count":49,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"unspecified","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2025,5,25]]},"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Retinoblastoma is the most common paediatric intraocular malignancy, originating in neural retina germ cells. Early diagnosis is crucial for survival and eye preservation. This study analyses gene expression and specific microRNAs (miRNAs) in patients with retinoblastoma to enhance early diagnosis, prognosis and treatment strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study examined gene and miRNA expression in 18 patients with retinoblastoma and 10 healthy individuals. Peripheral blood samples were collected from all participants, and patient demographics were recorded. The analysis was performed using real-time PCR targeting the RB1 and N-MYC genes, along with the miRNAs miR-125-5p, miR-221-3p and miR-519-3p.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The patient group consisted of 18 participants (9 males, 9 females), aged between 2 and 6 years (mean\u00b1SD: 4.8\u00b11.33 years), with a mean diagnosis age of 3.01\u00b11.37 years. All participants were followed for 3 years, with no fatalities. The control group comprised 10 participants (4 males, 6 females), aged 2\u20138 years (mean\u00b1SD: 5.01\u00b11.77 years). 11 patients underwent enucleation due to tumour progression: 3 right eyes and 8 left eyes. Gene expression analysis showed significant downregulation of miR-125-5p, miR-519-3p and NMYC in the retinoblastoma group. RB1 downregulation and miR-221-3p upregulation were noted in most patients, but without significant associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>miRNAs, along with RB1 and N-MYC genes, may serve as predictive and prognostic biomarkers in retinoblastoma. While previous studies have highlighted the impact of certain miRNAs on survival and clinical outcomes, our study is limited by a small sample size and lack of strong statistical correlations. Large-scale studies are needed to validate these preliminary findings and clarify their clinical significance. Understanding the role of miRNAs in cancer biology could improve retinoblastoma mechanism insights and patient care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjophth-2024-002093","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T23:20:12Z","timestamp":1749597612000},"page":"e002093","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Insights into retinoblastoma pathogenesis: unraveling RB1, N-MYC and miRNA profiles"],"prefix":"10.1136","volume":"10","author":[{"given":"Mohammad","family":"Faranoush","sequence":"first","affiliation":[{"name":"Pediatric Growth and Development Research Center, Institute of Endocrinology Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Khesali","sequence":"additional","affiliation":[{"name":"Pediatric Growth and Development Research Center, Institute of Endocrinology Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9329-6426","authenticated-orcid":false,"given":"Pooya","family":"Faranoush","sequence":"additional","affiliation":[{"name":"Pediatric Growth and Development Research Center, Institute of Endocrinology Iran University of Medical Sciences, Tehran, Iran"},{"name":"Mehresoheila cancer charity, Alborz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Foroughi-Gilvaee","sequence":"additional","affiliation":[{"name":"Pediatric Growth and Development Research Center, Institute of Endocrinology Iran University of Medical Sciences, Tehran, Iran"},{"name":"Mehresoheila cancer charity, Alborz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parisa","family":"Shams","sequence":"additional","affiliation":[{"name":"Cell and Developmental Biology Department, Faculty of sciences and advanced Technologies in biology, University of Science and Culture, ACECR, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negin","family":"Sadighnia","sequence":"additional","affiliation":[{"name":"Pediatric Growth and Development Research Center, Institute of Endocrinology Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyyed Amir Yasin","family":"Ahmadi","sequence":"additional","affiliation":[{"name":"Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorsa","family":"Fallah Azad","sequence":"additional","affiliation":[{"name":"Pediatric Growth and Development Research Center, Institute of Endocrinology Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Nekouian","sequence":"additional","affiliation":[{"name":"Pediatric Growth and Development Research Center, Institute of Endocrinology Iran University of Medical Sciences, Tehran, Iran"},{"name":"Mehresoheila cancer charity, Alborz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"2026010721205699000_10.1.e002093.1","first-page":"313","article-title":"Clinical Outcomes of Pediatric Cancer Patients with COVID-19: A Cross-Sectional Study","volume":"18","author":"Arian","year":"2024","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"2026010721205699000_10.1.e002093.2","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.25134","article-title":"ATP-Binding Cassette Transporter Genes and microRNAs in Pediatric B-Cell ALL: Expression Insights","volume":"39","author":"Nekouian","year":"2025","journal-title":"J Clin Lab Anal"},{"key":"2026010721205699000_10.1.e002093.3","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70922","article-title":"Delving Into Retinoblastoma Genetics: Discovery of Novel Mutations and Their Clinical Impact: Retrospective Cohort Study","volume":"14","author":"Faranoush","year":"2025","journal-title":"Cancer Med"},{"key":"2026010721205699000_10.1.e002093.4","doi-asserted-by":"crossref","DOI":"10.1186\/s40246-023-00529-w","article-title":"Genetics in ophthalmology: molecular blueprints of retinoblastoma","volume":"17","author":"Markovi\u0107","year":"2023","journal-title":"Hum Genomics"},{"key":"2026010721205699000_10.1.e002093.5","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1016\/S2214-109X(21)00555-6","article-title":"Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors","volume":"10","author":"Wong","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2026010721205699000_10.1.e002093.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.06.018"},{"key":"2026010721205699000_10.1.e002093.7","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(22)00250-9"},{"key":"2026010721205699000_10.1.e002093.8","first-page":"381","article-title":"Consequences of delayed diagnosis in treatment of retinoblastoma","volume":"24","author":"Faranoush","year":"2014","journal-title":"Iran J Pediatr"},{"key":"2026010721205699000_10.1.e002093.9","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13020179","article-title":"High-Frequency (30 MHz-6 GHz) Breast Tissue Characterization Stabilized by Suction Force for Intraoperative Tumor Margin Assessment","volume":"13","author":"Mokhtari Dowlatabad","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"2026010721205699000_10.1.e002093.10","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05222-9","article-title":"E2F1\/CKS2\/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis"},{"key":"2026010721205699000_10.1.e002093.11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24781-7","article-title":"Retinoblastoma from human stem cell-derived retinal organoids","volume":"12","author":"Norrie","year":"2021","journal-title":"Nat Commun"},{"key":"2026010721205699000_10.1.e002093.12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70045-7"},{"key":"2026010721205699000_10.1.e002093.13","first-page":"197","article-title":"Genetics and Molecular Diagnostics in Retinoblastoma--An Update","volume":"6","author":"Soliman","year":"2017","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"2026010721205699000_10.1.e002093.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2022.104674"},{"key":"2026010721205699000_10.1.e002093.15","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102807","article-title":"Retinoblastoma Tumor Suppressor Protein Roles in Epigenetic Regulation","volume":"12","author":"Guzman","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026010721205699000_10.1.e002093.16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25792-0","article-title":"A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal\/ganglion cell gene expression","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"2026010721205699000_10.1.e002093.17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/13816810.2021.1923038","article-title":"MYCN amplification levels in primary retinoblastoma tumors analyzed by Multiple Ligation-dependent Probe Amplification","volume":"42","author":"Price","year":"2021","journal-title":"Ophthalmic Genet"},{"key":"2026010721205699000_10.1.e002093.18","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-022-00409-3","article-title":"MYCN induces cell-specific tumorigenic growth in RB1-proficient human retinal organoid and chicken retina models of retinoblastoma","volume":"11","author":"Blixt","year":"2022","journal-title":"Oncogenesis"},{"key":"2026010721205699000_10.1.e002093.19","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026010721205699000_10.1.e002093.20","doi-asserted-by":"publisher","DOI":"10.4110\/in.2011.11.1.11"},{"key":"2026010721205699000_10.1.e002093.21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.708765","article-title":"Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications","volume":"11","author":"Otmani","year":"2021","journal-title":"Front Oncol"},{"key":"2026010721205699000_10.1.e002093.22","first-page":"2285","article-title":"MicroRNA\u2011503 serves an oncogenic role in retinoblastoma progression by directly targeting PTPN12","volume":"18","author":"Cheng","year":"2019","journal-title":"Exp Ther Med"},{"key":"2026010721205699000_10.1.e002093.23","doi-asserted-by":"crossref","DOI":"10.3390\/genes14071375","article-title":"miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer","volume":"14","author":"Chakrabortty","year":"2023","journal-title":"Genes (Basel)"},{"key":"2026010721205699000_10.1.e002093.24","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/cbin.11041","article-title":"Retraction: MiR\u2010506\u20103p inhibits cell proliferation, induces cell cycle arrest and apoptosis in retinoblastoma by directly targeting NEK6 by Lina Wu, Zhen Chen, Yiqiao Xing","volume":"43","year":"2019","journal-title":"Cell Biol Int"},{"key":"2026010721205699000_10.1.e002093.25","first-page":"4331","article-title":"miR-145 regulates the proliferation and apoptosis of Y79 human retinoblastoma cells by targeting IGF-1R","volume":"11","author":"Chen","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"key":"2026010721205699000_10.1.e002093.26","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180776","article-title":"MiR-140-5p suppresses retinoblastoma cell growth via inhibiting c-Met\/AKT\/mTOR pathway","volume":"38","author":"Liao","year":"2018","journal-title":"Biosci Rep"},{"key":"2026010721205699000_10.1.e002093.27","doi-asserted-by":"crossref","first-page":"109111","DOI":"10.1016\/j.biopha.2019.109111","article-title":"MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN\/Akt pathway","volume":"118","author":"Wan","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"2026010721205699000_10.1.e002093.28","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2020\/e1804","article-title":"microRNA-144 functions as a diagnostic and prognostic marker for retinoblastoma","volume":"75","author":"Zheng","year":"2020","journal-title":"Clinics (Sao Paulo)"},{"key":"2026010721205699000_10.1.e002093.29","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2460\/javma.23.03.0162","article-title":"Dextranase enzyme and Enterococcus faecium probiotic have anti-biofilm effects by reducing the count of bacteria in dental plaque in the oral cavity of dogs","volume":"261","author":"Sadighnia","year":"2023","journal-title":"J Am Vet Med Assoc"},{"key":"2026010721205699000_10.1.e002093.30","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/vms3.1109","article-title":"Evaluation of the in vitro and in vivo effect of liposomal doxorubicin along with oncolytic Newcastle disease virus on 4T1 cell line: Animal preclinical research","volume":"9","author":"Faranoush","year":"2023","journal-title":"Vet Med Sci"},{"key":"2026010721205699000_10.1.e002093.31","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01223-z","article-title":"Retinoblastoma: present scenario and future challenges","volume":"21","author":"Byroju","year":"2023","journal-title":"Cell Commun Signal"},{"key":"2026010721205699000_10.1.e002093.32","first-page":"1292","article-title":"Differential gene expression profile of retinoblastoma compared to normal retina","volume":"16","author":"Ganguly","year":"2010","journal-title":"Mol Vis"},{"key":"2026010721205699000_10.1.e002093.33","doi-asserted-by":"publisher","DOI":"10.3980\/j.issn.2222-3959.2011.01.24"},{"key":"2026010721205699000_10.1.e002093.34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189736","article-title":"RB1 gene mutations in Argentine retinoblastoma patients. Implications for genetic counseling","volume":"12","author":"Parma","year":"2017","journal-title":"PLoS ONE"},{"key":"2026010721205699000_10.1.e002093.35","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.survophthal.2024.05.009","article-title":"Role of MYCN in retinoblastoma: A review of current literature","volume":"69","author":"Vempuluru","year":"2024","journal-title":"Surv Ophthalmol"},{"key":"2026010721205699000_10.1.e002093.36","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.3390\/cancers12092714","article-title":"Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma","volume":"12","author":"Zugbi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026010721205699000_10.1.e002093.37","doi-asserted-by":"crossref","first-page":"100188","DOI":"10.1016\/j.xops.2022.100188","article-title":"High-Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures","volume":"2","author":"Roohollahi","year":"2022","journal-title":"Ophthalmology Science"},{"key":"2026010721205699000_10.1.e002093.38","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154537","article-title":"miRNAs as potential game-changers in retinoblastoma: Future clinical and medicinal uses","volume":"247","author":"Doghish","year":"2023","journal-title":"Pathology - Research and Practice"},{"key":"2026010721205699000_10.1.e002093.39","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-017-3421-3","article-title":"miRNome landscape analysis reveals a 30 miRNA core in retinoblastoma","volume":"17","author":"Castro-Magdonel","year":"2017","journal-title":"BMC Cancer"},{"key":"2026010721205699000_10.1.e002093.40","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S305098"},{"key":"2026010721205699000_10.1.e002093.41","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-10-59","article-title":"Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells","volume":"10","author":"Shu","year":"2011","journal-title":"Mol Cancer"},{"key":"2026010721205699000_10.1.e002093.42","doi-asserted-by":"publisher","DOI":"10.1101\/gad.17027411"},{"key":"2026010721205699000_10.1.e002093.43","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1080\/15384101.2021.1971352","article-title":"Long non-coding RNA PROX1-AS1 knockdown upregulates microRNA-519d-3p to promote chemosensitivity of retinoblastoma cells via targeting SOX2","volume":"20","author":"Chen","year":"2021","journal-title":"Cell Cycle"},{"key":"2026010721205699000_10.1.e002093.44","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1080\/09168451.2018.1553604","article-title":"Downregulation of EIF5A2 by miR-221-3p inhibits cell proliferation, promotes cell cycle arrest and apoptosis in medulloblastoma cells","volume":"83","author":"Yang","year":"2019","journal-title":"Biosci Biotechnol Biochem"},{"key":"2026010721205699000_10.1.e002093.45","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5819-6","article-title":"miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo","volume":"19","author":"Kiener","year":"2019","journal-title":"BMC Cancer"},{"key":"2026010721205699000_10.1.e002093.46","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.cellsig.2016.04.002","article-title":"Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation","volume":"28","author":"Zhang","year":"2016","journal-title":"Cell Signal"},{"key":"2026010721205699000_10.1.e002093.47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076320","article-title":"miR-125b-5p, miR-155-3p, and miR-214-5p and Target E2F2 Gene in Oral Squamous Cell Carcinoma","volume":"24","author":"Go\u0142\u0105bek","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026010721205699000_10.1.e002093.48","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.01155","article-title":"Non-Coding RNAs in Retinoblastoma","volume":"10","author":"Plousiou","year":"2019","journal-title":"Front Genet"},{"key":"2026010721205699000_10.1.e002093.49","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1591"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2024-002093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:21:50Z","timestamp":1767849710000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2024-002093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,6,10]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1136\/bmjophth-2024-002093"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2024-002093","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}